Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E446	Deputy Chief \| Chemopreventive Agent Development
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E430	Program Officer \| Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E438	Program Officer \| Chemopreventive Agent Development
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E542	Deputy Chief \| Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E536	Program Officer \| Chemopreventive Agent Development
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E538	Program Officer \| Chemopreventive Agent Development

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Matin, Khalid	Virginia Commonwealth University United States	VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program	3UG1CA189869-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mcguire, Andrew	Fred Hutchinson Cancer Center United States	Rational Vaccine Design to prevent HIV-Associated Lymphoma	5R01CA285227-02
Mclouth, Laurie	University Of Kentucky United States	Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment	5R01CA283929-03	Brennan Streck, Ph.D., RN, M.P.H.
Md, Nicholas Dibella	Western States Cancer Research Ncorp United States	NCORP: Colorado Cancer Research Program	3UG1CA189805-11S1	Vanessa A. White, M.P.H.
Meghani, Salimah H.	University Of Pennsylvania United States	Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study	3R01CA270483-04S1	Gabriela Riscuta, M.D., CNS
Mehrara, Babak J	Sloan-Kettering Inst Can Research United States	Mechanisms of racial disparity in breast cancer-related lymphedema	5R01CA278599-03
Mehta, Anand S.	Medical University Of South Carolina United States	Glycan Biomarkers for Cholangiocarcinoma	1R01CA289381-01A1	Sidney Fu, M.D.
Melemedjian, Ohannes Kevork	University Of Maryland Baltimore United States	Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy	4R01CA249939-02	Rachel Altshuler, Ph.D.
Mello-Thoms, Claudia R	University Of Iowa United States	Satisfaction of Search in Breast Cancer Detection	5R01CA259048-05
Metzger, Gregory John	University Of Minnesota United States	Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI	4R01CA241159-05	Guillermo Marquez, Ph.D.
Milanovich, Samuel J.	Sanford Research/Usd United States	Sanford Community Cancer Program of the North Central Plains (NCORP)	3UG1CA189825-11S1	Vanessa A. White, M.P.H.
Milbury, Kathrin	University Of Tx Md Anderson Can Ctr United States	Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers	4R37CA231522-07	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Miyano, Masaru	Beckman Research Institute/City Of Hope United States	Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials	1R03CA300614-01	Sidney Fu, M.D.
Morilak, David A	University Of Texas Hlth Science Center United States	Therapy-induced cognitive impairment in a rat model of prostate cancer	5R01CA285183-03	John Clifford, Ph.D.
Morin, Olivier	University Of California, San Francisco United States	Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity	1R01CA292043-01A1	Marjorie Perloff, M.D.

Chemopreventive Agent Development

On This Page

Major Programs

Staff List

Grants